Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial

Overview of attention for article published in International Journal of Hematology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 1,415)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 3 news stories from 3 outlets.

Una terapia di mantenimento con bortezomib due volte alla settimana non pare migliorare la profondit della risposta n…

May 10, 2018 No improvement in the depth of response was observed during the maintenance phase, and 50% of patients experienced…

May 8, 2018 Maintenance therapy with biweekly bortezomib did not improve depth of response or prolong progression-free survival…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.